Credence

CPHI Milan Draws 63,000 Industry Professionals as Global Pharma Participation Grows


Key Points

  • CPHI Milan 2026 drew more than 63,000 professionals from 168 countries, up more than 6% from 2024, with more than 2,800 exhibiting companies.
  • The program featured more than 320 speakers and over 200 sessions, plus an inaugural Sustainability Summit with more than 370 sustainability professionals.
  • Organizers are now focused on CPHI Frankfurt 2027, building on the scale and international participation established in Milan.

CPHI Milan recorded its largest attendance to date, bringing together more than 63,000 pharmaceutical industry professionals from 168 countries for three days of business development, technical discussions and networking.

Held October 6-8 at Fiera Milano, the 2026 event saw attendance increase by more than 6% compared with the previous Milan edition in 2024. More than 2,800 companies exhibited, representing a broad cross-section of the pharmaceutical supply chain and showcasing products, technologies and services spanning drug development and manufacturing.

The conference program featured more than 320 speakers from leading pharmaceutical organizations, with over 200 sessions addressing some of the industry’s most pressing challenges and opportunities. Topics included emerging investment opportunities in the pharmaceutical sector, strategies for strengthening supply chains and the evolution toward Manufacturing 5.0.

Sustainability also received expanded attention through the inaugural Sustainability Summit. Running alongside the main event over two days, the program attracted more than 370 sustainability professionals, pharmaceutical executives and supply chain representatives. More than 50 sessions focused on practical approaches to advancing sustainability across pharmaceutical operations and the broader supply chain.

Tara Dougal, Event Director for CPHI Milan, says the attendance figures demonstrate the continued importance of the event as an international meeting point for pharmaceutical companies and industry stakeholders. She highlighted the opportunity for participants to explore new technologies, exchange expertise and develop relationships across the sector.

Dougal also points to the introduction of the Sustainability Summit as an example of the event’s efforts to expand its programming in response to industry priorities. Organizers are now turning their attention to the next edition, CPHI Frankfurt 2027, with plans to build on the scale and international participation established in Milan.

Attendees represented the pharmaceutical industry’s full value chain, including manufacturers, innovators, distributors, consulting organizations, contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). Finished dosage forms, active pharmaceutical ingredients (APIs), and biopharmaceutical and pharmaceutical products were among the leading areas of interest.

Now in its 37th year, CPHI will return in 2027 with its Frankfurt event, where organizers plan to further expand the international platform for pharmaceutical business, innovation and industry collaboration.

Learn more at www.cphi.com.